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Abst rac t
Background and purpose: According to official statistics, 
the stroke mortality rate has remained high in Eastern Euro-
pean countries for a few decades. It has been shown that also
in Poland stroke mortality failed to decline in the period 1984
to 1992. Since that time, stroke management in our country
has changed, especially in the cities, where stroke units have
been developed. The aim of the present study was to compa-
re incidence and case fatality rates, estimated on the basis of
two prospective population-based studies performed in War-
saw in 1991/1992 and 2005.
Material and methods: Incidence rates and case fatality rates
for the first-ever-in-a-lifetime stroke have been estimated on
the basis of two population-based studies: the Warsaw Stro-
ke Registry (population 182 649) conducted in 1991 and
1992, and the European Register of Stroke (population
120 186) – registration in 2005. In both studies data were
standardized to the European population by the direct
methods.
Results: Contrary to the incidence rates, which did not chan-
ge significantly between 1991/1992 and 2005, 30-day and 
1-year case fatality rates decreased significantly from 43% 
to 14.9% and from 59.7% to 33.1%, respectively.
Incidence and case fatality rates of first-ever stroke – comparison of data 
from two prospective population-based studies conducted in Warsaw
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St reszczenie
Wstêp i cel pracy: Zgodnie z oficjalnymi statystykami,
w Europie Wschodniej od kilku dziesiêcioleci wskaŸniki
umieralnoœci i œmiertelnoœci z powodu udaru mózgu s¹ bar-
dzo wysokie. We wczeœniejszych badaniach epidemiologicz-
nych prowadzonych w Polsce w latach 1984–1992 nie stwier-
dzono spadku umieralnoœci z powodu udaru. Od tamtego
czasu istotnie zmieni³a siê jednak opieka nad chorymi na udar
mózgu, szczególnie w miastach, gdzie stworzone zosta³y
oddzia³y udarowe. Celem tej pracy jest porównanie wskaŸni-
ków zapadalnoœci i œmiertelnoœci z powodu udaru mózgu na
podstawie dwóch badañ populacyjnych prowadzonych w War-
szawie w latach 1991/1992 i 2005 r.
Materia³ i metody: Na podstawie dwóch badañ populacyj-
nych: Warszawskiego Rejestru Udarów (liczebnoœæ popula-
cji – 182 649), prowadzonego w latach 1991/1992, i badania
populacyjnego prowadzonego w ramach projektu European
Registers of Stroke (liczebnoœæ populacji – 120 186) w roku
2005, porównywano wskaŸniki zapadalnoœci i œmiertelnoœci
z powodu pierwszego w ¿yciu udaru mózgu. W obu bada-
niach wskaŸniki standaryzowano do populacji europejskiej
metod¹ bezpoœredni¹.
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Introduction
Stroke mortality rates vary considerably by country
[1,2]. According to official statistics, Poland has one of
the highest stroke mortality rates in Europe, which
seems to result mainly from high case fatality rates.
Population-based studies conducted in the 1980s and
1990s showed that Poland had an incidence of stroke
similar to that of other countries but a very high morta-
lity rate and a very high 30-day case fatality rate for first-
ever-in-a-lifetime stroke (FEL), exceeding 30% [3,4].
A World Health Organization (WHO) report based
on information from death certificates showed that the
stroke mortality rate in Poland increased between 1970
and 1985 [5]. In addition, stroke mortality failed to dec-
line between 1984 and 1992 because neither the case
fatality rate nor the stroke incidence rate decreased [4,6].
In recent decades, mortality due to cardiovascular dise-
ase has declined in many countries [7-10]; this trend
has been observed in Poland as well [11-13].
The aim of this study was to compare the incidence,
30-day, and 1-year case fatality rates for FEL based on
prospective population-based stroke registries conduc-
ted in Warsaw in 1991/1992 [3,14] and 2005.
Material and methods
Two 2-year, prospective, population-based stroke
registries were conducted in Warsaw. The first, the War-
saw Stroke Registry (WSR), aimed to register FEL
among permanent residents of the Ursynów and Moko-
tów districts in Warsaw from January 1, 1991 to Decem-
ber 31, 1992 (population as of 1991: 182 649; 85 791
males and 96 858 females) [3,4,14]. The second study,
conducted as part of the European Register of Stroke
Project (EROS), registered FELs among permanent
residents of the Ursynow District in Warsaw between
January 1, 2005 and December 31, 2005 (population:
120 186; 56 816 males and 63 370 females). The sour-
ce population was estimated from a constantly updated
official population register which was based on an avail-
able census from 2002 [15]. The two populations were
similar with respect to socio-economic parameters and
risk factor profiles (see Results section).
Cases were ascertained similarly in both studies: case
subjects were ascertained by screening all hospitals that
admitted acute stroke patients from the studied popu-
lation. Patients not admitted to hospitals were identified
by regular screening of all primary care facilities (e.g.,
general practitioners and outpatient clinics) and nursing
homes in the study area and by checking death certifi-
cates; specially trained fieldworkers or neurologists from
the study group performed these activities. Moreover,
before the project was started, all hospital physicians,
general practitioners, nursing institutions, and health
authorities in the study area were contacted, informed
of the study, and asked to report suspected cases of stro-
ke to the study centre: the Institute of Psychiatry and
Neurology. The data for both studies were collected by
standardized questionnaire. All study participants were
Caucasian.
Stroke was defined according to WHO criteria as
a rapid onset of clinical signs of focal or global distur-
bance of cerebral function lasting more than 24 hours
or leading to death, with no apparent nonvascular cau-
se [1]. Stroke was classified as cerebral infarction or pri-
mary intracerebral haemorrhage based on computed
tomography (CT)/magnetic resonance imaging scans,
examination of cerebrospinal fluid, or necropsy. Cases
without confirmation of stroke subtype were classified
as undefined. In some cases, CT scan was repeated 
7 days after stroke. Patients with subarachnoid haemor-
Conclusions: Comparison of data from two population-based
prospective stroke registries showed that stroke case fatality
and mortality significantly decreased. This may be associa-
ted with the better management of patients in the acute pha-
se of stroke and implementation of secondary prevention stra-
tegies for stroke.
Key words: stroke, epidemiology, incidence, case fatality.
Wyniki: WskaŸniki zapadalnoœci nie zmieni³y siê istotnie
pomiêdzy latami 1991–1992 a 2005 r., natomiast wskaŸniki
œmiertelnoœci 30-dniowej i rocznej znamiennie zmniejszy³y
siê odpowiednio z 43% do 14,9% i z 59,7% do 33,1%.
Wnioski: Porównanie danych z dwóch populacyjnych reje-
strów pierwszego w ¿yciu udaru mózgu pokaza³o wyraŸne
zmniejszenie wskaŸników œmiertelnoœci. Mo¿e to wynikaæ
z poprawy opieki nad pacjentami z udarem mózgu w fazie
ostrej, jak równie¿ z wdra¿ania zasad profilaktyki wtórnej
udaru mózgu.
S³owa kluczowe: udar mózgu, epidemiologia, zapadalnoœæ,
œmiertelnoœæ. 
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rhage (SAH) were excluded from the analysis because
they were not included in the WSR.
Crude incidence rates for FEL were calculated for
the whole population, by age group, and according to
sex, and expressed per 100 000 population. Stroke mor-
tality was calculated as 30-day fatality (%) and one-year
mortality rates expressed per 100 000 population. Age-
specific rates were calculated for seven age groups 
in ten-year intervals, starting from 0-35 years up to 
74 years. The oldest groups were analysed according to
age 75 to 79 years and greater than or equal to 80 years.
Total incidence rates and mortality rates were age-adju-
sted to the standard European population [16] because
there were significant differences in age distribution
between the two analysed populations (Table 1). Confi-
dence intervals (CI) for the incidence rate estimates were
calculated using the Poisson distribution. Statistical ana-
lyses were performed using CIA software.
The study was approved by the Ethics Committee
of the Institute of Psychiatry and Neurology (22/2004).
Results
Between January 1, 2005 and December 31, 2005,
127 residents of the Ursynow District were registered
with FEL. The majority of these patients were admit-
ted to the Institute of Psychiatry and Neurology; a few
were admitted to other hospitals (up to 5%). Overall,
in 2005, 97% of FEL patients were hospitalized, 
the majority in stroke units, and 3% were treated in out-
patient clinics. In 1991/1992, the proportion of patients
hospitalized was 78%; 15% were treated in outpatient
clinics.
The diagnosis of stroke was confirmed by CT in
98% in 2005. Based on the neuroimaging, ischaemic
stroke was diagnosed in 90.3%, intracerebral haemor-
rhage in 8%, and about 2% were unclassified. The age
of the patients ranged from 34 to 93 years (mean ± SD:
69.5 ± 13.1 years) in 2005 and 18 to 97 years in
1991/1992 (mean ± SD: 69.0 ± 13.9 years). The pro-
portions of men and women in the two studies were
similar: in 2005, 51.2% and in 1991/1992, 51.5% of
patients were female.
In 2005, the prevalence of hypertension was 75.8%
and atrial fibrillation was present in 25%. The prevalen-
ce of diabetes was 10.7%. More than 30% of stroke
patients were current smokers. In general, the risk fac-
tor profiles for patients in the 1991/1992 study were simi-
lar: atrial fibrillation was diagnosed in 22.8% of patients
and diabetes in about 15%. Although the proportion of
patients with hypertension in 1991/1992 was lower (57%)
than in 2005, the percentage of patients with undiagno-
sed and untreated hypertension before stroke was higher
(33% vs 10% for 1991/1992 and 2005 respectively).
Data for incidence, case fatality rate, and mortality
rate for 1991/1992 were published previously [3,4,6,14].
Stroke incidence in 2005 was estimated on the basis of
patient registers established as part of the European Regi-
sters of Stroke [15]. The crude annual incidence of FEL
was 105.7 per 100 000 (confidence interval [CI], 
86-112); 109.1/100 000 for men and 102.5/100 000 for
women). After standardization to the European popula-
tion by a direct method [16], the incidence rates for
FEL were 139.6 per 100 000 for men (CI, 124-173),
120.4 per 100 000 for women (CI, 105-150), and 128.9
per 100 000 for the general population. Age-specific inci-
Age, years WSR, 1991/1992 EROS, 2005
Number % of total population (95% CI) Number % of total population (95% CI)
<35 82 520 45.2 (45.0-45.4) 54 876 45.7 (45.4-45.9)
35-44 31 856 17.4 (17.3-17.6) 12 072 10.0 (9.9-10.2)
45-54 22 235 12.2 (12.0-12.3) 29 901 24.9 (24.6-25.1)
55-64 23 257 12.7 (12.6-12.9) 14 431 12.0 (11.8-12.2)
65-74 13 301 7.3 (7.2-7.4) 5724 4.8 (4.6-4.9)
75-79 4375 2.4 (2.3-2.5) 1628 1.4 (1.3-1.4)
≥ 80 5105 2.8 (2.7-2.9) 1554 1.3 (1.2-1.4)
Total 182 649 100.0 120 186 100.0
Table 1. Profile of populations in the Warsaw Stroke Registry (WSR) (1991/1992) and European Register of Stroke Project (EROS) study (2005)
CI – confidence interval
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dence rates for both sexes increased sharply with age. In
2005 the rates for people older than 75 years of age were
higher than in 1991/1992 (Table 2).
Age-specific 30-day case fatality rates were lower in
2005 than in 1991/1992 (Fig. 1). In total, 30-day case
fatality rates decreased from 43% in 1991/1992 to
14.9% in 2005. 
The crude annual mortality rate of FEL in 2005 
was 34.9 and in 1991/1992, 75.5. Age-specific one-year
mortality rates were lower in 2005 than in 1991/1992
(Table 3).
Discussion
The present study demonstrated a significant decli-
ne in stroke case fatality rate between 1991/1992 and
2005/2006. Thirty-day case fatality rates decreased from
43% in 1991/1992 to 12.9% in 2005/2006, and one-
year case fatality rates decreased from 59.7% to 24.0%.
According to official statistics, stroke case fatality and
mortality rates in Poland were unchanged over the past
few decades, whereas the average annual stroke morta-
lity rate has declined by up to 7% in many countries 
since 1970 [5,17]. A prospective population-based stu-
dy conducted in Warsaw in 1991/1992 revealed one of
the highest 1-year stroke mortality rates in Europe
(106/100 000 in men and 78/100 000 in women) [4,6].
These findings were confirmed by the Pol-MONICA
study [18,19].
Both the present study and the WSR were prospec-
tive population-based studies with a high case ascertain-
ment. Our results regarding incidence are similar to
estimates made in other epidemiological studies from
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Fig. 1. Age-specific 30-day case fatality rate (%) for first-ever-in-a-lifetime
stroke in Warsaw. Data are from two population-based studies 
conducted in 1991/1992 and 2005. Error bars indicate the 95% confidence
intervals
2005
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Poland and Western Europe [2,3,14,20]. The most up-
to-date population-based study in Poland, which was
performed in Krakow, showed slightly higher inciden-
ce rates for stroke than those reported here; however,
21% of those cases were recurrent strokes and 8% were
SAH [21]. In our study, SAH account for about 6.7%
of all FELs. Similar to our results, 30-day and 1-year
case fatality rates for all strokes in Krakow were lower
than those previously reported (in WSR 43% at 30 days
and 59.7% at 1 year), and reached 17.8% and 39.7%,
respectively [21]. 
The last decade has brought significant changes in
stroke management in Poland, as well as establishing
modern stroke services [22]. Current stroke epide-
miology in Warsaw is comparable to that in other Euro-
pean countries. In southern Sweden, the age-standar-
dized incidence rate in 2001/2002 was 144 per 100 000
and the 30-day case fatality rate was 14% [23]. The de -
cline in case fatality rates in the Warsaw population
could reflect the improvements in the management of
acute stroke and an increased awareness of stroke symp-
toms on the part of emergency medical personnel. In
Warsaw in 2005/2006, 95% of patients with acute stroke
were treated in specialized stroke units and 97% were
hospitalized, as compared to 87% in 1991/1992. A well-
developed network of stroke units allows for early inten-
sive treatment with recombinant tissue-type plasmino-
gen activator (rt-PA) as well as the early implementation
of secondary prevention strategies. All hospitalized
patients in 2005/2006 were offered early rehabilitation.
Moreover, these patients have been routinely followed
in the outpatient clinic since their stroke. Secondary pre-
vention measures were implemented in the hospital and
maintained in the outpatient setting. Lower case fatali-
ty rates can be mainly attributed to better control of car-
diovascular risk factors before the occurrence of stroke.
It is likely that changes in lifestyle during the last two
decades that brought a decline in heart disease morta-
lity in Poland also influenced the stroke case fatality rate.
The use of antihypertensive medication before stroke
has increased since 1991/1992 and untreated hyperten-
sion is diagnosed much more rarely. In addition, a posi-
tive trend in smoking habits was observed between 1996
and 2004 in men, in whom the percentage of current
smokers decreased from 47.3% to 38% [24,25].
Our results offer an example of the efficacy of a well-
developed system for acute stroke service and long-term
care for stroke patients. However, it should be stressed
that our study encompassed a population of permanent
residents of Warsaw districts, which is not representa-
tive of the general population of Poland. Results from
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the Polish National Stroke Prevention and Treatment
Registry showed great differences in in-hospital morta-
lity from ischaemic stroke between participating centres,
ranging from 8% to 32% [26].
Conclusions
1. Information from a population-based prospective
stroke registry in Warsaw (EROS) revealed a stroke
incidence rate similar to that in other European coun-
tries.
2. The decrease in the stroke case fatality rate detected
here is likely the result of better management of acute
stroke and the implementation of secondary prevention
strategies.
3. Results from Warsaw demonstrate a positive trend in
stroke outcome, which has also been observed in other
urban areas of Poland.
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